BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2024 8:28:55 AM | Browse: 187 | Download: 433
 |
Received |
|
2024-04-23 15:39 |
|
Peer-Review Started |
|
2024-04-23 15:39 |
|
First Decision by Editorial Office Director |
|
2024-07-25 06:05 |
|
Return for Revision |
|
2024-07-27 14:16 |
|
Revised |
|
2024-08-08 14:39 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-08-19 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-08-19 06:51 |
|
Articles in Press |
|
2024-08-19 06:51 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-08-21 10:16 |
|
Publish the Manuscript Online |
|
2024-08-29 08:28 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Timing of antiviral therapy in patients with hepatitis B virus related hepatocellular carcinoma undergoing hepatectomy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dong-Ling Wan and Li-Qi Sun |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Li-Qi Sun, MD, Doctor, Doctor, Department of Gastroenterology, Changhai Hospital, Naval Medical University, No. 168 Changhai Road, Yangpu District, Shanghai 200433, China. zjhzslqsmmu@foxmail.com |
| Key Words |
Hepatitis B virus-DNA; Hepatitis B virus-DNA; Antiviral therapy; Hepatectomy; Hepatitis B virus; Hepatocellular carcinoma |
| Core Tip |
Hepatocellular carcinoma (HCC) is one of the most common and highly fatal malignancies worldwide and is usually associated with hepatitis B virus (HBV) infection. Hepatectomy is a widely accepted curative treatment for HCC, but the long-term survival rate is still unsatisfactory due to the high recurrence rate after resection. Preoperative or postoperative antiviral therapy plays an important role in improving the prognosis for HBV-related HCC patients who underwent hepatectomy. Therefore, we explored when antiviral therapy is more appropriate and whether perioperative rescue antiviral therapy can achieve the effect of preoperative long-term antiviral therapy in the paper. |
| Publish Date |
2024-08-29 08:28 |
| Citation |
Wan DL, Sun LQ. Timing of antiviral therapy in patients with hepatitis B virus related hepatocellular carcinoma undergoing hepatectomy. World J Clin Oncol 2024; 15(9): 1251-1255 |
| URL |
https://www.wjgnet.com/2218-4333/full/v15/i9/1251.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v15.i9.1251 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
